doxazosin and 2,4,6-trimethyl-n-(meta-3-trifluoromethylphenyl)benzenesulfonamide

doxazosin has been researched along with 2,4,6-trimethyl-n-(meta-3-trifluoromethylphenyl)benzenesulfonamide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Arroyave-Ospina, JC; Buist-Homan, M; Damba, T; Moshage, H; Muñoz-Ortega, MH; Serna-Salas, SA; Ventura-Juárez, J; Zhang, M	1

Other Studies

1 other study(ies) available for doxazosin and 2,4,6-trimethyl-n-(meta-3-trifluoromethylphenyl)benzenesulfonamide

Article	Year
α-1 Adrenergic receptor antagonist doxazosin reverses hepatic stellate cells activation via induction of senescence. Mechanisms of ageing and development, 2022, Volume: 201 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Animals; Cell Cycle Checkpoints; Cell Proliferation; Cells, Cultured; Cellular Senescence; Doxazosin; Hepatic Stellate Cells; Liver Cirrhosis; Norepinephrine; Rats; Receptors, Adrenergic, alpha-1; Senescence-Associated Secretory Phenotype; Signal Transduction; Sulfonamides	2022

Article

Year

α-1 Adrenergic receptor antagonist doxazosin reverses hepatic stellate cells activation via induction of senescence.

Mechanisms of ageing and development, 2022, Volume: 201

Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Animals; Cell Cycle Checkpoints; Cell Proliferation; Cells, Cultured; Cellular Senescence; Doxazosin; Hepatic Stellate Cells; Liver Cirrhosis; Norepinephrine; Rats; Receptors, Adrenergic, alpha-1; Senescence-Associated Secretory Phenotype; Signal Transduction; Sulfonamides

2022